Target intelligence / Profile preview

NGRN pseudogene 1 (NGRNP1)

Target
NGRNP1
Molecular classification
Other (Pseudogene)
01

Overview

NGRN pseudogene 1 (NGRNP1) is a human pseudogene, meaning it is a non-coding genomic element derived from the duplication or retrotransposition of a parental protein-coding gene. Unlike its parental gene (if identified), NGRNP1 does not produce a functional protein. Pseudogenes in general can participate in genome regulation by acting as decoys for microRNAs, generating regulatory RNAs such as lncRNAs, or affecting gene expression via antisense mechanisms, but for the majority of pseudogenes—including NGRNP1—these regulatory roles are speculative and largely undocumented[1][2][3][4]. Pseudogenes are not considered bona fide therapeutic targets. If you need structured data or mappings for a database, NGRNP1 would map as a pseudogene and should not be listed as a druggable or actionable target. If encountered in a target selection context, it should be flagged as non-target and likely incorrect for most pharmaceutical or mechanistic studies[1][2][3][4].

02

Mechanism of action

None established

03

Biological functions

Regulatory non-coding RNA effects (possible, but not established for NGRNP1 specifically)Other (General to pseudogenes: can act as microRNA sponges, create long non-coding RNAs, serve antisense regulatory functions)
04

Disease associations

Other (no disease associations known for NGRNP1; note some pseudogenes have been implicated in cancer or as biomarkers)

Beyond the preview

Go deeper on NGRN pseudogene 1 (NGRNP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NGRN pseudogene 1 (NGRNP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call